STUDY OF LONG-TERM CLINICAL AND PATHOGENETIC EFFECTS OF FAVIPIRAVIR-BASED ANTI-VIRAL DRUG IN PATIENTS WITH METABOLIC SYNDROME IN POST-COVID PERIOD

STUDY OF LONG-TERM CLINICAL AND PATHOGENETIC EFFECTS OF FAVIPIRAVIR-BASED ANTI-VIRAL DRUG IN PATIENTS WITH METABOLIC SYNDROME IN POST-COVID PERIOD

The article presents modern scientific data on long-term clinical and pathogenetic effects of the antiviral drug Areplivir (Favipiravir) in patients with metabolic syndrome in the post-COVID period.The aim of the article is to study long-term cytokine-mediated (IL-6/sIL6r and LIF/sLIFr) pathogenetic...

Full description

Bibliographic Details
Main Authors: O. A. Radaeva, L. A. Balykova, K. Ya. Zaslavskaya, A. V. Taganov, P. A. Bely, Yu. A. Kostina, E. V. Negodnova, S. V. Mashnina, D. D. Bessheinov, M. S. Iskandyarova, V. V. Eremeev, N. M. Chumakov
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2022-05-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
арепливир
фавипиравир
covid-19
постковидный синдром
метаболический синдром
Online Access:https://www.pharmpharm.ru/jour/article/view/1079

Internet

https://www.pharmpharm.ru/jour/article/view/1079

Similar Items